Miller Richard

The North Dakota Department of Health (NDDoH) investigated the feasibility of using syndromic surveillance (SyS) data to identify health care visits due to electronic cigarette (e-cigarette) use. E-cigarettes have been associated with injuries and fatalities in all age groups, including young children attracted to the colorful liquid nicotine carriage packaging [1]. Previously, poison control data was the only resource available to the NDDoH for e-cigarette adverse outcomes surveillance.

Objective

To explore the use of emergency department syndromic surveillance data to identify adverse health events related to electronic cigarettes in order in enhance existing surveillance.

Objective

Wisconsin is leading the way in novel approaches monitoring health outcomes for opioid-related adverse events. This panel will share innovative public health informatics methods that harness various data sources (e.g., Prescription Drug Monitoring Data (PDMP), death, birth and hospitalization data) for population health surveillance. Discussion will include topics on detection of drug abuse and diversion, identifying potential neonatal abstinence syndrome cases, surveillance of substance-related hospitalizations and overdose deaths, and modeling opioid-related mortality risk factors.

There is a resurgence in the need to evaluate the economic burden of prescription drug hospitalizations in the United States. We used the Wisconsin 2014 Hospital Discharge data to examine opioid related hospitalization incidence and costs. Fentanyl, a powerful synthetic opioid, is frequently being used for as an intraoperative agent in anesthesia, and post-operative recovery in hospitals. According to a 2013 study, synthetic Fentanyl is 40 times more potent than heroin and other prescription opioids; the strength of Fentanyl leads to substantial hospitalizations risks. Since, 1990 it has been available with a prescription in various forms such as transdermal patches or lollipops for treatment of serious chronic pain, most often prescribed for late stage cancer patients. There have been reported fatal overdoses associated with misuse of prescription fentanyl. In Wisconsin number of total opioid related deaths increased by 51% from 2010 to 2014 with the number of deaths involving prescription opioids specifically increased by 23% and number of deaths involving heroin increased by 192%. We hypothesized that opioids prescription drugs, as a proxy of Fentanyl use, result in excessive health care costs.

Objective

In this paper we used hospital charges to assess costs incurred due to prescription drug/opioid hospitalizations